Alzheimer's Disease (AD) is a progressively debilitating form of dementia that affects millions
of individuals worldwide. Although a vast amount of research has investigated the complex …

Being isolated from the peripheral system by the blood–brain barrier, the brain has long
been considered a completely impervious tissue. However, recent findings show that the gut …

A growing body of evidence suggests that the gut microbiota contributes to the development
of neurodegenerative diseases via the microbiota-gut-brain axis. As a contributing factor …

Over the past decades, microbiome research has evolved rapidly and became a hot topic in
basic, preclinical and clinical research, for the pharmaceutical industry and for the general …

Gut microbiota has emerged as an important key regulator of health and disease status.
Indeed, gut microbial dysbiosis has been identified in an increasing number of diseases …

Shifts in the magnitude and nature of gut microbial metabolites have been implicated in
Alzheimer's disease (AD), but the host receptors that sense and respond to these …

A common symptom in Alzheimer's disease (AD) is cognitive decline, of which the potential
pathogenesis remains unclear. In order to understand the mechanism of gut microbiota in …

Developing novel agents for unexplored targets to combat Alzheimer's disease (AD)
represents an urgent task due to its increasing prevalence worldwide. The present paper …

Although an intriguing potential association of the gut microbiome with Alzheimer's disease
(AD) has attracted recent interest, few studies have directly assessed this relationship or …

Background The gut microbiome is composed of various microorganisms such as bacteria,
fungi, and protozoa, and constitutes an important part of the human gut. Its composition is …